MY ACCOUNT | NEWSLETTER |

Tiny Molecules, Big Possibilities: Texas A&M Researchers Explore A New Way To Slow Lung Cancer

New university findings highlight potential implications for veterinary patients, cancer, and veterinary practice.


Peter Nghiem collaborated on a study showing that two naturally occurring microRNAs may help slow the growth of non-small cell lung cancer by restoring normal cellular regulation.

A new Texas A&M study identifies naturally occurring microRNAs that help regulate cell growth and could one day support targeted cancer therapies.

Cancer develops when the body’s normal systems for controlling cell growth break down, allowing cells to multiply unchecked.

Now, Texas A&M researchers have identified two naturally occurring molecules that appear to help restore those controls, offering a potential new strategy for slowing the progression of lung cancer.

In a recent study , researchers from the Texas A&M College of Veterinary Medicine & Biomedical Sciences (VMBS) and the College of Education & Human Development found that microRNA-15a and microRNA-16 — small molecules that help regulate protein production within cells — can significantly reduce the growth and protein synthesis of non-small cell lung cancer cells.

The findings add to a growing body of research suggesting that these microRNAs play an important role in maintaining cellular balance and could someday serve as targets for therapies designed to slow cancer progression.

“These two specific microRNAs have a profound influence on cellular proteostasis, and the disruption of cellular proteostasis in most cancer cells is the reason that they become cancerous,” said Dr.

James Fluckey , associate dean for research and a professor in the Department of Kinesiology & Sport Management and the study’s principal investigator.

“The fact that we found two mircoRNAs that can influence that proteostasis to slow cancer progression is of profound importance.” Every cell constantly receives signals telling it when to grow, divide, repair itself, or slow down.

MicroRNAs help regulate those signals, ensuring cells maintain a healthy balance.

Peter Nghiem , a VMBS associate professor and co-author on the study, compared microRNAs to traffic lights.

The report adds to ongoing university-led research relevant to veterinary medicine, animal health, and clinical decision-making.

Source university website: Texas A&M VMBS

https://vetmed.tamu.edu/news/press-releases/micrornas-lung-cancer-cell-growth/

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

The combination of lomustine and corticosteroids is a valid chemotherapeutic option in cats with presumptive central nervous system lymphoma.

Like0
Dislike0

Efficacy of Oral Baicalin in Canine Atopic Dermatitis A Randomised Placebo Controlled Trial.

Like0
Dislike0

Efficacy of dietary onion powder (Allium cepa L.) as a phytogenic feed additive Effects on growth performance, blood biochemistry, gut morphology, and immune function in broiler chickens.

Like0
Dislike0

Boehringer Ingelheim reports first-half 2026 sales growth, driven by JARDIANCE® and new product launches in the U.S.

Like0
Dislike0

Ultrasonographic characteristics of renal lymphoma in cats receiving chemotherapy.

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top